We know that #SARSCoV2 has mutated whilst spreading around the globe – but will this affect the efficacy of vaccines in development? In our paper published today, we explain why we don’t think so. 📰: 1/12
“neutral evolution, rather than adaptive selection, can explain the rare mutations seen across SARS-CoV-2 genomes” “limited diversity seen in SARS-CoV-2 should not preclude a single vaccine from providing global protection”
Our Commentary (1st link) on the perspective of low level genetic diversity in SARS-CoV-2 (companion to Dearlove et al., 2nd link) has now been published in PNAS! #COVID19 #SARSCoV2 #evolution #viruses
The intensity of dissection of the #SARSCoV2 genome's ~30,000 base pairs has been nothing short of remarkable and how this plays out for a universal vaccine
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants 🤞🏼🤞🏼🤞🏼
. PNAS: Universality of a potential #SARSCoV2 #vaccine
"A single vaccine candidate should be efficacious against currently circulating lineages."